Cargando…
Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish
Hepatocellular carcinoma (HCC) is one of the most lethal human cancers. The search for targeted treatments has been hampered by the lack of relevant animal models for the genetically diverse subsets of HCC, including the 20-40% of HCCs that are defined by activating mutations in the gene encoding β-...
Autores principales: | Evason, Kimberley J., Francisco, Macrina T., Juric, Vladislava, Balakrishnan, Sanjeev, Lopez Pazmino, Maria del Pilar, Gordan, John D., Kakar, Sanjay, Spitsbergen, Jan, Goga, Andrei, Stainier, Didier Y. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489858/ https://www.ncbi.nlm.nih.gov/pubmed/26134322 http://dx.doi.org/10.1371/journal.pgen.1005305 |
Ejemplares similares
-
Heterogeneous beta-catenin activation is sufficient to cause hepatocellular carcinoma in zebrafish
por: Kalasekar, Sharanya M., et al.
Publicado: (2019) -
Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish
por: Ju, Bensheng, et al.
Publicado: (2009) -
Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma
por: Kotiyal, Srishti, et al.
Publicado: (2021) -
An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening
por: Nguyen, Anh Tuan, et al.
Publicado: (2012) -
Phospholipid isotope tracing reveals β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma
por: VanSant-Webb, Chad, et al.
Publicado: (2023)